On March 18, 2021, BGI announced the donation of 40,000 Rapid Identification Kits for SARS-CoV-2 variants to the Ministry of Health of Angola, to support the local fight against the pandemic. The kits arrived earlier this month in Luanda, the capital of Angola.
At the online ceremony, Silvia Lutucuta, the Minister of Health of Angola, said: “In the face of new challenges brought by the COVID-19 variants, BGI once again lent a helping hand and provided Identification Kits for SARS-CoV-2 variants to Angola. On behalf of the Angolan government, we express our heartfelt thanks.”
On July 16, 2020, the Angolan government commissioned BGI to build Huo-Yan Laboratories in four cities with a total daily testing capacity of 6,000 samples to fight against the pandemic. In the second half of 2020, four laboratories were opened successively. The 18 local laboratory experts were trained by BGI.
Angolan Minister of Health Silvia Lutucuta (top right), and Gong Tao, Chinese Ambassador to Angola (bottom left), attend the ceremony onsite in Angola. Li Ning, Vice President of BGI (top left, second from left) attended online.
Recently, three SARS-CoV-2 variants–the lineage B.1.1.7 first identified in England, and the lineages B.1.351 and P1 initially discovered in South Africa and Brazil have gained global attention.
In response to the new COVID-19 mutants, BGI monitors the emergence of additional SARS-CoV-2 variants of concern and develops a variety of identification kits for B.1.1.7, B.1.351, and P1. We have also developed a new NGS-based Genome Analysis Solution, which can detect mutations in new variants with high-quality genome sequencing results.
BGI provides a full range of COVID-19 nucleic acid detection kits, antibody detection kits and antigen detection kits together with identification kits. The series of product and applications can meet the clinical needs of various scenarios and contribute to the global COVID-19 prevention and control work.